Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.

Japanese journal of cancer research : Gann - 1 Sept 1996

Zhang S, Endo S, Koga H, Ichikawa T, Feng X, Onda K, Washiyama K, Kumanishi T

Abstract excerpt

A total of 10 glioma cell lines were examined for alterations of the p16, p15, p53 and p21 genes, which are tumor suppressor genes or candidates with direct or indirect CDK-inhibitory functions. Genetic alterations (deletions or mutations) were frequently seen in the p16, p15 and p53 genes in these cell lines, but not in the p21 gene. When the states of the p16, p15 and p53 genes were compared among cell lines,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carrier Proteins
Share to Cell Cycle Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Gene Deletion

Share to Genes, p53

Share to Genes, Tumor Suppressor

Share to Methylation

Source

Open in PubMed Open full text

Identifiers

PMID: 8878451
DOI: 10.1111/j.1349-7006.1996.tb02118.x
PMCID: PMC5921198

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations.PMID 8878451Read ↗

Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas.Semantic proximity Read ↗

Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.Semantic proximity Read ↗

Frequent Co‐Alterations of <i>TP53, p16/CDKN2A, p14</i><sup>ARF</sup>, <i>PTEN</i> Tumor Suppressor Genes in Human Glioma Cell Lines.Semantic proximity Read ↗

Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas.Semantic proximity Read ↗

Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.Semantic proximity Read ↗

Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.Semantic proximity Read ↗

Loss of P16INK4 expression is frequent in high grade gliomas.Semantic proximity Read ↗

Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.Semantic proximity Read ↗

Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes.Semantic proximity Read ↗

Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells.Semantic proximity Read ↗

Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma.Semantic proximity Read ↗

Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.